ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

Researchers Link Obesity With 34% Higher Death Risk In Pre-Menopausal Women

May 30, 2014

Other DCT Concepts Approved By Board

February 26, 1988

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

June 16, 1995

ASCO Supports Tobacco Tax Increase

March 7, 2003

House panel examines use of grant funds.

September 23, 2005